Our research brings together a highly qualified team of clinicians, laboratory scientists, public health scientists, and patient advocates from the Fred Hutchinson Cancer Research Center and seven other institutions to form a unique resource for inter-institutional collaborative breast biomarker research. The goal of our research is to evaluate a variety of breast cancer biomarkers for their contribution to early detection of breast cancer, particularly those markers which identify aggressive forms of breast cancer missed by mammography. The objectives of our research are:
To validate and refine the ability of candidate biomarkers to predict disease status;
To evaluate panels of biomarkers for use as an adjunct to mammography, and to report the improvement in diagnostic performance attributable to the addition of the marker panel relative to mammography alone; and
To identify the molecular signatures of subsets of in situ and invasive breast cancers and explore their associations with biomarkers in the panel.
Participating Institutions
Our research brings together clinicians, laboratory scientists, public health scientists, and patient advocates from the Fred Hutchinson Cancer Research Center and seven other institutions across the U.S. and Canada.
